Anti-HCV testing is clearly the most effective strategy, but various policies can be adopted given the uncertainties of scientific and cost data. We recommended that surrogate tests be used in addition to the anti-HCV test in all French blood banks.
Other output or dissemination activity: This is the current French policy.